Pfizer COVID-19 VACCINE 90 PERCENT EFFECTIVE IN PHASE 3 TRIAL

Highlights

• Albert Bourla, Chairman and CEO of Pfizer said “The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID-19.” 

• Pfizer said the results of its COVID-19 ...

SOUTH KOREAN PHARMAS JOIN NATION-FRAUGHT RACE TO DEVELOP COVID-19 VACCINE

• South Korean pharmaceutical companies have joined the rat race to develop vaccines and treatments for the novel coronavirus, and several of them have received the nod for clinical trials from the country's drug safety agency.
• Among the front-runners is Celltrion Inc.'s ...